<DOC>
	<DOCNO>NCT01486264</DOCNO>
	<brief_summary>This study compare Xeomin® , botulinum toxin medication , short treatment interval ( Short Flex dose ) standard interval dosing ( Long Flex dosing ) determine response treatment comparable work side effect . Xeomin® approve United States Food Drug Administration ( FDA ) treatment cervical dystonia ( CD ) . The use Xeomin® investigational regard shorter treatment interval . An investigational use one approve FDA .</brief_summary>
	<brief_title>Open-Label Non-Inferiority Study Evaluating Efficacy Safety Xeomin® Subjects With Cervical Dystonia Flex</brief_title>
	<detailed_description>Dystonia movement disorder characterize sustain , involuntary muscle contraction frequently cause twist repetitive movement abnormal posture trunk , neck , face , arm legs . In focal dystonia , abnormal movement involve single area body . A commonly describe form focal dystonia cervical dystonia ( CD ) . Botulinum toxin treatment offer treatment option treatment CD . The current practice botulinum toxin injection treatment inject patient every 3 month . However , patient receive continue benefit botulinum toxin injection entire 3 month . In recent survey , approximately 45 % patient report would prefer treatment cycle le 10 weeks.This study compare Xeomin® , botulinum toxin treatment , short treatment interval ( Short Flex dose ) standard interval dosing ( Long Flex dosing ) determine response treatment comparable work side effect . Xeomin® approve United States Food Drug Administration ( FDA ) treatment CD . The use Xeomin® investigational regard shorter treatment interval . An investigational use one approve FDA . The purpose research study evaluate efficacy Short Flex dose Xeomin® compare Long Flex dose regimen Xeomin® , use standard scale complete doctor subject well questionnaires ask subject rate symptom CD .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Documented clinical diagnosis idiopathic genetic Cervical Dystonia Current treatment botulinum toxin type indication ( include aesthetic indication ) body region study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>